[Federal Register Volume 83, Number 158 (Wednesday, August 15, 2018)]
[Notices]
[Pages 40567-40568]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17605]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Rhodes
Technologies
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before October 15, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the
Controlled Substances Act to the Administrator of the Drug Enforcement
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all
necessary functions with respect to the promulgation and implementation
of 21 CFR part 1301, incident to the registration of manufacturers,
distributors, dispensers, importers, and exporters of controlled
substances (other than final orders in connection with suspension,
denial, or revocation of registration) has been delegated to the
Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June
28th, 2018, Rhodes Technologies, 498 Washington Street, Coventry, Rhode
Island 02816 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana........................... 7360 I
Tetrahydrocannabinols............... 7370 I
Dihydromorphine..................... 9145 I
Methylphenidate..................... 1724 II
Codeine............................. 9050 II
Dihydrocodeine...................... 9120 II
Oxycodone........................... 9143 II
Hydromorphone....................... 9150 II
Hydrocodone......................... 9193 II
Levorphanol......................... 9220 II
Morphine............................ 9300 II
Oripavine........................... 9330 II
Thebaine............................ 9333 II
Oxymorphone......................... 9652 II
Noroxymorpohone..................... 9668 II
Tapentadol.......................... 9780 II
------------------------------------------------------------------------
[[Page 40568]]
The company plans to manufacture the listed controlled substances
in bulk for conversion and sale to finished dosage form manufacturers.
In reference to drug code 7360 and 7370, the company plans to bulk
manufacture a synthetic CBD and tetrahydrocannabinol. No other activity
for drug code 7360 and 7370 are authorized for this registration.
Dated: August 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-17605 Filed 8-14-18; 8:45 am]
BILLING CODE 4410-09-P